{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T13:56:39Z","timestamp":1778162199284,"version":"3.51.4"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T00:00:00Z","timestamp":1597276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T00:00:00Z","timestamp":1597276800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s00296-020-04676-4","type":"journal-article","created":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T16:10:19Z","timestamp":1597335019000},"page":"1593-1598","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":82,"title":["Coronavirus disease 2019 (COVID-19) in autoimmune and inflammatory conditions: clinical characteristics of poor outcomes"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4594-7663","authenticated-orcid":false,"given":"Fernando","family":"Montero","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9670-1746","authenticated-orcid":false,"given":"Julia","family":"Mart\u00ednez-Barrio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7805-1359","authenticated-orcid":false,"given":"Bel\u00e9n","family":"Serrano-Benavente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4713-0737","authenticated-orcid":false,"given":"Teresa","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8147-5881","authenticated-orcid":false,"given":"Javier","family":"Rivera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5191-7802","authenticated-orcid":false,"given":"Juan","family":"Molina Collada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1811-2417","authenticated-orcid":false,"given":"Isabel","family":"Castrej\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0343-3747","authenticated-orcid":false,"given":"Jose","family":"\u00c1lvaro-Gracia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,8,13]]},"reference":[{"issue":"8","key":"4676_CR1","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1056\/NEJMoa2001017","volume":"382","author":"N Zhu","year":"2019","unstructured":"Zhu N, Zhang D, Wang W et al (2019) (2020) A Novel Coronavirus from Patients with Pneumonia in China. N Engl J Med 382(8):727\u2013733","journal-title":"N Engl J Med"},{"key":"4676_CR2","unstructured":"Gobierno de Espa\u00f1a. Ministerio de Sanidad. Secretaria General de sanidad. Direcci\u00f3n General de salud p\u00fablica, calidad e informaci\u00f3n. Centro de Coordinaci\u00f3n de Alertas y Emergencias Sanitarias. (Government of Spain. Ministry of Health. General Secretary of Health. General Directorate of Public Health, Quality and Information. Center for Coordination of Health Alerts and Emergencies) (2020). Enfermedad por el coronavirus (COVID-19). (Coronavirus disease (COVID-19)) Actualizaci\u00f3n n\u00ba 104. https:\/\/www.mscbs.gob.es\/profesionales\/saludPublica\/ccayes\/alertasActual\/nCov-China\/documentos\/Actualizacion_104_COVID-19.pdf"},{"key":"4676_CR3","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-217763","author":"JL Pablos","year":"2020","unstructured":"Pablos JL, Abasolo L, Alvaro-Gracia JM et al (2020) Prevalence of hospital PCR-confirmed COVID-19 cases in patients with chronic inflammatory and autoimmune rheumatic diseases. Ann Rheum Dis. https:\/\/doi.org\/10.1136\/annrheumdis-2020-217763","journal-title":"Ann Rheum Dis"},{"key":"4676_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2020.05.001","author":"X Michelena","year":"2020","unstructured":"Michelena X, Borrell H, Lopez-Corbeto M et al (2020) Incidence of COVID-19 in a cohort of adult and paediatric patients with rheumatic diseases treated with targeted biologic and synthetic disease-modifying anti-rheumatic drugs. Semin Arthritis Rheum. https:\/\/doi.org\/10.1016\/j.semarthrit.2020.05.001","journal-title":"Semin Arthritis Rheum"},{"key":"4676_CR5","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-217322","author":"G Figueroa-Parra","year":"2020","unstructured":"Figueroa-Parra G, Aguirre-Garcia GM, Gamboa-Alonso CM, Camacho-Ortiz A, Galarza-Delgado DA (2020) Are my patients with rheumatic diseases at higher risk of COVID-19? Ann Rheum Dis. https:\/\/doi.org\/10.1136\/annrheumdis-2020-217322","journal-title":"Ann Rheum Dis"},{"key":"4676_CR6","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-217681","author":"E Conticini","year":"2020","unstructured":"Conticini E, Bargagli E, Bardelli M et al (2020) COVID-19 pneumonia in a large cohort of patients treated with biological and targeted synthetic antirheumatic drugs. Ann Rheum Dis. https:\/\/doi.org\/10.1136\/annrheumdis-2020-217681","journal-title":"Ann Rheum Dis"},{"key":"4676_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(20)30095-3","author":"MA Gianfrancesco","year":"2020","unstructured":"Gianfrancesco MA, Hyrich KL, Gossec L et al (2020) Rheumatic disease and COVID-19: initial data from the COVID-19 Global Rheumatology Alliance provider registries. Lancet Rheumatol. https:\/\/doi.org\/10.1016\/S2665-9913(20)30095-3","journal-title":"Lancet Rheumatol"},{"issue":"5","key":"4676_CR8","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1007\/s00134-020-05991-x","volume":"46","author":"Q Ruan","year":"2020","unstructured":"Ruan Q, Yang K, Wang W, Jiang L, Song J (2020) Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan China. Intensive Care Med 46(5):846\u2013848","journal-title":"Intensive Care Med"},{"issue":"6","key":"4676_CR9","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.jinf.2020.03.037","volume":"80","author":"Q Ye","year":"2020","unstructured":"Ye Q, Wang B, Mao J (2020) The pathogenesis and treatment of the `Cytokine Storm' in COVID-19. J Infect 80(6):607\u2013613","journal-title":"J Infect"},{"issue":"10229","key":"4676_CR10","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","volume":"395","author":"F Zhou","year":"2020","unstructured":"Zhou F, Yu T, Du R et al (2020) Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 395(10229):1054\u20131062","journal-title":"Lancet"},{"key":"4676_CR11","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2020.0994","author":"C Wu","year":"2020","unstructured":"Wu C, Chen X, Cai Y et al (2020) Risk factors Associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan China. JAMA Intern Med. https:\/\/doi.org\/10.1001\/jamainternmed.2020.0994","journal-title":"JAMA Intern Med"},{"issue":"10223","key":"4676_CR12","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","volume":"395","author":"N Chen","year":"2020","unstructured":"Chen N, Zhou M, Dong X et al (2020) Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 395(10223):507\u2013513","journal-title":"Lancet"},{"issue":"1","key":"4676_CR13","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1056\/NEJMc2009567","volume":"383","author":"R Haberman","year":"2020","unstructured":"Haberman R, Axelrad J, Chen A et al (2020) Covid-19 in Immune-Mediated Inflammatory Diseases - Case Series from New York. N Engl J Med 383(1):85\u201388","journal-title":"N Engl J Med"},{"key":"4676_CR14","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-217888","author":"KM D'Silva","year":"2020","unstructured":"D'Silva KM, Serling-Boyd N, Wallwork R et al (2020) Clinical characteristics and outcomes of patients with coronavirus disease 2019 (COVID-19) and rheumatic disease: a comparative cohort study from a US \u2018hot spot'. Ann Rheum Dis. https:\/\/doi.org\/10.1136\/annrheumdis-2020-217888","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"4676_CR15","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1136\/annrheumdis-2020-217424","volume":"79","author":"S Monti","year":"2020","unstructured":"Monti S, Balduzzi S, Delvino P, Bellis E, Quadrelli VS, Montecucco C (2020) Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies. Ann Rheum Dis 79(5):667\u2013668","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"4676_CR16","doi-asserted-by":"publisher","first-page":"e343","DOI":"10.1371\/journal.pmed.0030343","volume":"3","author":"LJ Stockman","year":"2006","unstructured":"Stockman LJ, Bellamy R, Garner P (2006) SARS: systematic review of treatment effects. PLoS Med 3(9):e343","journal-title":"PLoS Med"},{"issue":"10223","key":"4676_CR17","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/S0140-6736(20)30317-2","volume":"395","author":"CD Russell","year":"2020","unstructured":"Russell CD, Millar JE, Baillie JK (2020) Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury. Lancet 395(10223):473\u2013475","journal-title":"Lancet"},{"key":"4676_CR18","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2020.05.032","author":"EJ Brenner","year":"2020","unstructured":"Brenner EJ, Ungaro RC, Gearry RB et al (2020) Corticosteroids, but not TNF antagonists, are associated with adverse COVID-19 outcomes in patients with inflammatory bowel diseases: results from an international registry. Gastroenterology. https:\/\/doi.org\/10.1053\/j.gastro.2020.05.032","journal-title":"Gastroenterology"},{"issue":"7813","key":"4676_CR19","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/d41586-020-01824-5","volume":"582","author":"H Ledford","year":"2020","unstructured":"Ledford H (2020) Coronavirus breakthrough: dexamethasone is first drug shown to save lives. Nature 582(7813):469","journal-title":"Nature"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-020-04676-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-020-04676-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-020-04676-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,13]],"date-time":"2021-08-13T00:39:06Z","timestamp":1628815146000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-020-04676-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,13]]},"references-count":19,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["4676"],"URL":"https:\/\/doi.org\/10.1007\/s00296-020-04676-4","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,13]]},"assertion":[{"value":"10 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standard"}},{"value":"The authors declare that they have no competing interest. Patient and public involvement Patients and\/or the public were not involved in the design, or conduct, or reporting, or dissemination plans of this research. Patient consent for publication: waived by the local IRB.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}